Human IgG Subclasses against Enterovirus Type 71: Neutralization versus Antibody Dependent Enhancement of Infection

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Cao, Rui Yuan ^a   Dong, Da Yong ^a   Liu, Rui Ju ^b   Han, Jian Feng ^a   Wang, Guang Chuan ^a   Zhao, Hui ^a   Li, Xiao Feng ^a   Deng, Yong Qiang ^a   Zhu, Shun Ya ^a   Wang, Xiao Yu ^a   Lin, Fang ^a,c   Zhang, Fu Jun ^d   Chen, Wei ^a   Qin, E De ^a   Qin, Cheng Feng ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b LIAOCHENG PEOPLE'S HOSPITAL   (China)

^c Second Artillery General Hospital   (China)

^d Rizhao Traditional Chinese Medicine Hospital of Shandong Traditional Chinese Medicine University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; PROTEIN A;

ANTIBODY DEPENDENT ENHANCEMENT; ANTIBODY TITER; ARTICLE; CONJUGATION; CONTROLLED STUDY; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FRACTIONATION; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; VIRUS CONCENTRATION; VIRUS NEUTRALIZATION; VIRUS PURIFICATION;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CELL LINE, TUMOR; ENTEROVIRUS A, HUMAN; ENTEROVIRUS INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOGLOBULIN G; NEUTRALIZATION TESTS;

EID: 84877910544     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064024     Document Type: Article

References (37)

1. McMinn PC, (2002) An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 26: 91-107.
2. Schmidt NJ, Lennette EH, Ho HH, (1974) An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis 129: 304-309.
3. Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, et al. (2010) Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 10: 778-790.
4. Tan X, Huang X, Zhu S, Chen H, Yu Q, et al. (2011) The persistent circulation of enterovirus 71 in People's Republic of China: causing emerging nationwide epidemics since 2008. PLoS One 6: e25662.
5. Yang F, Ren L, Xiong Z, Li J, Xiao Y, et al. (2009) Enterovirus 71 outbreak in the People's Republic of China in 2008. J Clin Microbiol 47: 2351-2352.
6. Lin YW, Chang KC, Kao CM, Chang SP, Tung YY, et al. (2009) Lymphocyte and antibody responses reduce enterovirus 71 lethality in mice by decreasing tissue viral loads. J Virol 83: 6477-6483.
7. Abzug MJ, Keyserling HL, Lee ML, Levin MJ, Rotbart HA, (1995) Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin. Clin Infect Dis 20: 1201-1206.
8. Chung YC, Huang JH, Lai CW, Sheng HC, Shih SR, et al. (2006) Expression, purification and characterization of enterovirus-71 virus-like particles. World J Gastroenterol 12: 921-927.
9. Foo DG, Alonso S, Chow VT, Poh CL, (2007) Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide. Microbes Infect 9: 1299-1306.
10. Wu CN, Lin YC, Fann C, Liao NS, Shih SR, et al. (2001) Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 20: 895-904.
11. Yu CK, Chen CC, Chen CL, Wang JR, Liu CC, et al. (2000) Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice. J Biomed Sci 7: 523-528.
12. Wang SM, Chen IC, Su LY, Huang KJ, Lei HY, et al. (2010) Enterovirus 71 infection of monocytes with antibody-dependent enhancement. Clin Vaccine Immunol 17: 1517-1523.
13. Han JF, Cao RY, Deng YQ, Tian X, Jiang T, et al. (2011) Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo. Virol J 8: 106.
14. Mehlhop E, Ansarah-Sobrinho C, Johnson S, Engle M, Fremont DH, et al. (2007) Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner. Cell Host Microbe 2: 417-426.
15. Hofmeister Y, Planitzer CB, Farcet MR, Teschner W, Butterweck HA, et al. (2010) Human IgG subclasses: in vitro neutralization of and in vivo protection against West Nile virus. J Virol 85: 1896-1899.
16. Rodrigo WW, Block OK, Lane C, Sukupolvi-Petty S, Goncalvez AP, et al. (2009) Dengue virus neutralization is modulated by IgG antibody subclass and Fcgamma receptor subtype. Virology 394: 175-182.
17. Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV, (2004) Intravenous immunoglobulin for infectious diseases: back to the pre-antibiotic and passive prophylaxis era? Trends Pharmacol Sci 25: 306-310.
18. Cao R, Han J, Deng Y, Yu M, Qin E, et al. (2010) Presence of high-titer neutralizing antibodies against enterovirus 71 in intravenous immunoglobulin manufactured from Chinese donors. Clin Infect Dis 50: 125-126.
19. Luo ST, Chiang PS, Chao AS, Liou GY, Lin R, et al. (2009) Enterovirus 71 maternal antibodies in infants, Taiwan. Emerg Infect Dis 15: 581-584.
20. Rabenau HF, Richter M, Doerr HW, (2010) Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany. Med Microbiol Immunol 199: 45-51.
21. Cao RY, Han JF, Jiang T, Tian X, Yu M, et al. (2011) In vitro and in vivo characterization of a new enterovirus type 71-specific human intravenous immunoglobulin manufactured from selected plasma donors. J Clin Virol 51: 246-249.
22. Han JF, Cao RY, Tian X, Yu M, Qin ED, Qin CF, (2010) Producing infectious enterovirus type 71 in a rapid strategy. Virology J 7: 116.
23. Duhamel RC, Schur PH, Brendel K, Meezan E, (1979) pH gradient elution of human IgG1, IgG2 and IgG4 from protein A-sepharose. J Immunol Methods 31: 211-217.
24. Scharf O, Golding H, King LR, Eller N, Frazier D, et al. (2001) Immunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1. J Virol 75: 6558-6565.
25. Reed LJ, Muench H, (1938) A simple method of estimating fifty percent endpoints. American Journal of Epidemiology 27: 493-497.
26. Wang SM, Lei HY, Huang MC, Su LY, Lin HC, et al. (2006) Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis. J Clin Virol 37: 47-52.
27. Wang SM, Liu CC, (2009) Enterovirus 71: epidemiology, pathogenesis and management. Expert Rev Anti Infect Ther 7: 735-742.
28. Liu CC, Chou AH, Lien SP, Lin HY, Liu SJ,et al. Identification and characterization of a cross-neutralization epitope of Enterovirus 71. Vaccine 29: 4362-4372.
29. Jelley-Gibbs DM, Plitnick LM, Gosselin EJ, (1999) Differences in IgG subclass do not effect immune complex-enhanced T cell activation despite differential binding to antigen presenting cells. Hum Immunol 60: 469-478.
30. Mori S, Takeuchi T, Kanda T, (2008) Antibody-dependent enhancement of adeno-associated virus infection of human monocytic cell lines. Virology 375: 141-147.
31. Shih SR, Stollar V, Lin JY, Chang SC, Chen GW, et al. (2004) Identification of genes involved in the host response to enterovirus 71 infection. J Neurovirol 10: 293-304.
32. Brouwer KC, Lal AA, Mirel LB, Otieno J, Ayisi J, et al. (2004) Polymorphism of Fc receptor IIa for immunoglobulin G is associated with placental malaria in HIV-1-positive women in western Kenya. J Infect Dis 190: 1192-1198.
33. Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, et al. (2009) Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med 15: 794-797.
34. Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, et al. (2009) Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med 15: 798-801.
35. Sauter P, Lobert PE, Lucas B, Varela-Calvino R, Alm G, et al. (2007) Role of the capsid protein VP4 in the plasma-dependent enhancement of the Coxsackievirus B4E2-infection of human peripheral blood cells. Virus Res 125: 183-190.
36. Huisman W, Martina BE, Rimmelzwaan GF, Gruters RA, Osterhaus AD, (2009) Vaccine-induced enhancement of viral infections. Vaccine 27: 505-512.
37. Hocart MJ, Mackenzie JS, Stewart GA, (1990) Serum IgG subclass responses of humans to inactivated and live influenza A vaccines compared to natural infections with influenza A. J Med Virol. 30: 92-96.